Dr. Choi's lab develops neurobiological treatment methods for alcohol use disorder and related psychiatric and neurodegenerative diseases.
Dr. Choi's lab identifies and validates therapeutic targets for alcohol use disorder and comorbid psychiatric conditions using cutting-edge technologies in the areas of neuroscience, animal behaviors and pharmacology.
Under the leadership of principal investigator Doo-Sup Choi, Ph.D., the Neurobiology of Alcoholism and Drug Addiction Lab identifies and validates therapeutic targets for alcohol use disorder and comorbid and co-occurring psychiatric conditions.
Dr. Choi's lab applies state-of-the-art integrative neurobiological and pharmacological techniques to the study of addictive behaviors. To understand molecular mechanisms underpinning alcohol use disorder and comorbid psychiatric conditions, his team employs advanced technologies to translate the findings into clinical trials and applications. These technologies include fiber photometry, optogenetics, chemogenetics, circuit-specific ablation, circuit-specific stimulation and computational modeling.
Specific areas of research interest in our lab include:
Since its founding in 2005, the Neurobiology of Alcoholism and Drug Addiction Lab has been funded by the National Institutes of Health and other extramural funding sources.
Dr. Choi's lab is affiliated with these Mayo Clinic research areas:
Contact Dr. Choi about his lab's research on neurobiology of addiction and comorbid psychiatric conditions or for information about research training opportunities.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?